Smart Radiotherapy Biomaterials for Cancer Therapy and Imaging
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Targeting and Design".
Deadline for manuscript submissions: 10 December 2025 | Viewed by 824
Special Issue Editors
Interests: image-guided radiotherapy; smart material; medical image analysis
Special Issues, Collections and Topics in MDPI journals
Interests: smart radiotherapy biomaterials; customizable liquid biomaterial; LIFE biomaterial; immunotherapy; theranostics
Special Issue Information
Dear Colleagues,
Cancer is the second cause of death worldwide in 2024, and one of the main reasons for its poor therapy is due to traditional treatment modalities such as chemotherapy, radiotherapy, and/or surgery. The associated toxicity related to the traditional treatment methods elicits many studies to be conducted preclinically evaluating the use of smart radiotherapy biomaterials in cancer treatment. The acclimation of smart biomaterials to the fluctuating physiological parameters and any outward tensions makes them compelling influencers on many aspects of homeopathic technology. Smart biomaterials can enhance promising treatments and boost the administration of long-lasting diseases, and they are applied in the fields of drug delivery systems, regenerative medicine, radiotherapy, medical gadgets, and immunotherapy. Preclinical studies have demonstrated many advantages, such as active targeting, long circulation, low immunogenicity, controlled drug release, and reduced toxicological effects in utilizing nanocarriers as targeted therapy for malignant tumors. Smart biomaterials can offer tissue-demonstrated precise modulation in the immunity of a cancer patient.
The goal of this Special Issue is to emphasize topical progress in research on applying smart radiotherapy biomaterials in cancer treatment and imaging. We encourage investigators and scientists to contribute original research and review articles underlining the latest applications of smart radiotherapy biomaterials in cancer treatment and imaging.
We look forward to receiving your contributions.
Dr. Kai Ding
Dr. Michele Moreau
Dr. Debarghya China
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- multifunctional biomaterials
- theranostic biomaterials
- smart drug delivery systems
- nanobiomaterials
- cancer radiotherapy
- polymer-based biomaterials nanocarriers customizable biomaterials for cancer therapy and imaging smart nanomaterials
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
